Streetwise Biotechnology / Pharmaceuticals Articles


News Update

Partnership Greenlighted for Canadian Biotech and Chinese Health Products Firm

News Update
  ()
This regenerative medicine company moves one step closer to commercialization of its cell therapies in East Asia. read more >

NIH Selects Biopharma's Lead Asset for Commercialization Accelerator Program

Research Report
  ()
A Maxim Group analyst reported on news and upcoming catalysts for this late-stage drug developer. read more >

Biotech's Preliminary Immunotherapy Data 'Positive,' Earns Coverage in Medical Journal

Research Report
  ()
An H.C. Wainwright & Co. report reviewed both the results and an "unusual" highlight from this firm's trial in head-and-neck cancer. read more >
News Update

Life Science Company Sells Large Order of Non-Antibiotic Growth Promoter for Livestock

News Update
  ()
This is the second large shipment to the Philippine distributor. read more >

This Company Has Better Numbers than Tilray at 1/25th the Price

Contributed Opinion
  ()
Tilray's wild fluctuations have grabbed the headlines the past few days, but Fincom Investment Partners profiles a rapidly emerging player in the cannabis realm that the firm believes has much more to offer. read more >

Coverage Initiated on 'Emerging Antibiotics Growth Story with Multiple Levers for Upside'

Research Report
  ()
An H.C. Wainwright & Co. report outlined the investment thesis for this U.S.-based biopharmaceutical firm. read more >

Cancer Vaccine Developer Expands Its Collaboration with Merck

Research Report
  ()
A Mackie Research Capital report tells how this biotech will benefit from its new and existing programs with this specific partner. read more >
Management Q&A: View from the Top

Medical Use of Nitric Oxide Expands as Costs Come Down

Managment Q&A: View from the Top
  ()
Dr. Brett Earl, a practicing physician and a vice president and director of Nu-Med Plus, discusses the many uses of nitric oxide and Nu-Med Plus' unique, low-cost delivery system. read more >
News Update

U.S. Biotech Partner Obtains Marketing Authorization for ADHD Treatment in Taiwan

News Update
  ()
Permission has been obtained to distribute time-release capsules. read more >

Why Tiny ITUS's CAR-T Therapy Could Be a Big Deal in Cancer Treatment

Contributed Opinion
  ()
With CAR-T being the hottest space in cancer therapy, Daniel Carlson of Tailwinds Research profiles an innovative company that has been collaborating with a major cancer center. read more >

Canadian Biopharma to Outlicense Pain Drug to South Korean Firm

Research Report
  ()
An Echelon Wealth Partners report discussed the deal terms. read more >

Biopharma's Positive FDA Meeting Outlines Path Forward for Trial

Research Report
  ()
A ROTH Capital Partners note explained the outcome of the tête-a-tête and its implications. read more >

Final Approval of Biopharma's Lead Candidate Both Likely and Imminent

Research Report
  ()
A ROTH Capital Partners report provided the takeaways from a recent meeting with the management team for this company, which is targeting an orphan indication. read more >
News Update

Drug Company Receives $5 Million Milestone Payment

News Update
  ()
Company entitled to receive quarterly earn-out payments from patent agreement. read more >

Oncology-Focused Biotech Receives Orphan Status for AML Drug

Research Report
  ()
An H.C. Wainwright & Co. report provided an update on two of this company's four product candidates. read more >

Investor Opportunity Arises from Biopharma's Share Price Weakness on Competitor News

Research Report
  ()
An analyst discussed the implications to this firm of a competitive product's advancement. read more >
News Update

Neurosciences Company Reports Potential for Improved Safety Profile for Alzheimer's Treatment

News Update
  ()
The substance shows potential for an improved safety profile in direct comparison to other Amyloid Beta-Directed Antibodies in clinical development. read more >

Coverage Initiated on Developer of Brachytherapy Products for Cancer Treatment

Research Report
  ()
H.C. Wainwright & Co. analyst Jason Kolbert provided the rationale for investment in this company. read more >
News Update

As Nitric Oxide Comes Off Patent, Lower-Cost Options for Life Saving Drug Becoming Possible

  ()
Dr. Ronald Day, a pediatric cardiologist at the University of Utah, has been using nitric oxide to treat children with pulmonary hypertension. Now, with a court ruling invalidating much of a drug patent for nitric oxide, lower-cost options might become available. read more >

Biotech Marks Progress on Programs for Cancer, Infectious Diseases

Research Report
  ()
This firm, focused on immuno-oncology and infectious diseases including Ebola and Zika, is moving forward on a variety of fronts, according to a Maxim Group analyst. read more >

Biopharma Signs Multimillion-Dollar Deal for Key Products in China

Research Report
  ()
An H.C. Wainwright & Co. report reviewed the arrangement. read more >
News Update

U.S. Medical Device Firm Pursues ISO 13485 Certification

News Update
  ()
With this move, this company aims for fast-tracked regulatory approval for its nitric oxide delivery system. read more >

Cash Stream from Licensing Deal to Help Biopharma Advance Lead Drug

Research Report
  ()
A Laidlaw & Co. report discussed this firm's revenue and near-term, clinical catalysts. read more >

Biotech Releases White Paper on Alzheimer's Disease Candidate

  ()
A company focused on treatment of neurodegenerative diseases has issued a white paper discussing its lead candidate. read more >

Interim Readout for Pharma Trial 'Delivers Home Run'

Research Report
  ()
An H.C. Wainwright & Co. report discussed the implications of data indicating "overwhelming evidence of efficacy" for this company's nonantibiotic anti-infective for treatment of catheter-related bloodstream infections. read more >
Showing Results: 26 to 50 of 68 Prev Next

Get Our Streetwise Reports Life Sciences Report Newsletter Free and be the first to know!

A valid email address is required to subscribe

More Experts